Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.
J R Shapiro, … , S D Chipman, D W Rowe
J R Shapiro, … , S D Chipman, D W Rowe
Published February 1, 1992
Citation Information: J Clin Invest. 1992;89(2):567-573. https://doi.org/10.1172/JCI115622.
View: Text | PDF
Research Article

An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.

  • Text
  • PDF
Abstract

Mutations affecting the pro alpha 1(I) or pro alpha 2(I) collagen genes have been identified in each of the major clinical types of osteogenesis imperfecta. This study reports the presence of a heritable connective tissue disorder in a family with an osteopenic syndrome which has features of mild osteogenesis imperfecta but was considered idiopathic osteoporosis in the proband. At age 38, while still premenopausal, she was found to have osteopenia, short stature, hypermobile joints, mild hyperelastic skin, mild scoliosis, and blue sclerae. There was no history of vertebral or appendicular fracture. Hip and vertebral bone mineral density measurements were consistent with marked fracture risk. Delayed reduction SDS-PAGE of pepsin-digested collagens from dermal fibroblast cultures demonstrated an anomalous band migrating between alpha 1(I) and alpha 1(III). This band merged with the normal alpha-chains upon prereduction, indicating an unexpected cysteine residue. Cyanogen bromide peptide mapping suggested that the mutation was in the smaller NH2-terminal peptides. cDNA was reverse transcribed from mRNA and amplified by the polymerase chain reaction. A basepair mismatch between proband and control alpha 1(I) cDNA hybrids was detected by chemical cleavage with hydroxylamine:piperidine. The cysteine substitution was thus localized to alpha 1(I) exon 9 within the cyanogen bromide 4 peptide. Nucleotide sequence analysis localized a G----T point mutation in the first position of helical codon 43, replacing the expected glycine (GGT) residue with a cysteine (TGT). The prevalence of similar NH2-terminal mutations in subjects with this phenotype which clinically overlaps idiopathic osteoporosis remains to be determined.

Authors

J R Shapiro, M L Stover, V E Burn, M B McKinstry, A L Burshell, S D Chipman, D W Rowe

×

Total citations by year

Year: 2021 2017 2014 2013 2009 2008 2007 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 Total
Citations: 1 2 1 1 2 2 2 2 1 1 1 1 1 2 3 3 2 1 2 2 1 34
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (34)

Title and authors Publication Year
Dentinogenesis Imperfecta and Caries in Osteogenesis Imperfecta among Vietnamese Children
HT Nguyen, DC Vu, DM Nguyen, QD Dang, VK Tran, H Le, SM Tong
Dentistry Journal 2021
Genetic identification of a common collagen disease in Puerto Ricans via identity-by-descent mapping in a health system
GM Belbin, J Odgis, EP Sorokin, MC Yee, S Kohli, BS Glicksberg, CR Gignoux, GL Wojcik, TV Vleck, JM Jeff, M Linderman, C Schurmann, D Ruderfer, X Cai, A Merkelson, AE Justice, KL Young, M Graff, KE North, U Peters, R James, L Hindorff, R Kornreich, L Edelmann, O Gottesman, EE Stahl, JH Cho, RJ Loos, EP Bottinger, GN Nadkarni, NS Abul-Husn, EE Kenny
eLife 2017
The genetic implication of scoliosis in osteogenesis imperfecta: a review
G Liu, J Chen, Y Zhou, Y Zuo, S Liu, W Chen, Z Wu, N Wu
2017
Subarachnoid hemorrhage secondary to a ruptured middle cerebral aneurysm in a patient with osteogenesis imperfecta: a case report
T Hirohata, S Miyawaki, A Mizutani, T Iwakami, S Yamada, H Nishido, Y Suzuki, S Miyamoto, K Hoya, M Murakami, A Matsuno
BMC neurology 2014
Abundance of MMPs and Cysteine Cathepsins in Caries-affected Dentin
CM Vidal, L Tjäderhane, PM Scaffa, IL Tersariol, D Pashley, HB Nader, FD Nascimento, MR Carrilho
Journal of dental research 2013
Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model
E Daley, EA Streeten, JD Sorkin, N Kuznetsova, SA Shapses, SM Carleton, AR Shuldiner, JC Marini, CL Phillips, SA Goldstein, S Leikin, DJ McBride
Journal of Bone and Mineral Research 2009
Reflex Sympathetic Dystrophy, Migratory Osteoporosis, and Osteogenesis Imperfecta
K Carter, J Nielsen
Imaging of Arthritis and Metabolic Bone Disease 2009
Principles of Bone Biology
CJ Rosen, T Niu
Principles of Bone Biology 2008
Collagen
P Fratzl
2008
A Case of Type I Osteogenesis Imperfecta Differentially Diagnosed as a Cause of a Spinal Compression Fracture
SY Rhee, SY Moon, S Chon, IK Jeong, S Oh, KJ Ahn, HY Chung, J Woo, SW Kim, YS Kim, JW Kim
Journal of Korean Endocrine Society 2007
Bone Densitometry in Growing Patients
AJ Sawyer, LK Bachrach, EB Fung
2007
Bisphosphonate treatment in osteogenesis imperfecta: Which drug, for whom, for how long?
F Rauch, FH Glorieux
Annals of Medicine 2005
Osteogenesis imperfecta: a case with hand deformities
B Oz, N Olmez, A Memis
Clinical Rheumatology 2005
Osteogenesis imperfecta
F Rauch, FH Glorieux
The Lancet 2004
Relation of Pvu II site polymorphism in the COL1A2 gene to the risk of fractures in prepubertal Finnish girls
M Suuriniemi, A Mahonen, V Kovanen, M Alén, S Cheng
Physiological genomics 2003
Type I Collagen Racemization and Isomerization and the Risk of Fracture in Postmenopausal Women: The OFELY Prospective Study
P Garnero, P Cloos, E Sornay-Rendu, P Qvist, PD Delmas
Journal of Bone and Mineral Research 2002
Current Protocols in Human Genetics
RG Cotton, M Grompe
Current Protocols in Human Genetics 2001
Osteogenesis Imperfecta
F Antoniazzi, M Mottes, P Fraschini, PC Brunelli, L Tat??
Paediatric Drugs 2000
Collagen and Bone Strength
AL Boskey, TM Wright, RD Blank
Journal of Bone and Mineral Research 1999
Linkage, Association, and the Genetic Analysis of Bone Mineral Density and Related Phenotypes
RD Blank
Journal of Clinical Densitometry 1999
Bone Mineral Density and Its Change in White Women: Estrogen and Vitamin D Receptor Genotypes and Their Interaction
M Willing, M Sowers, D Aron, MK Clark, T Burns, C Bunten, M Crutchfield, D D'Agostino, M Jannausch
Journal of Bone and Mineral Research 1998
Metabolic Bone Disease and Clinically Related Disorders
FR Singer, SM Krane
Metabolic Bone Disease and Clinically Related Disorders 1998
Genetic and environmental factors affecting bone mineral density in large families
SS Yeap, M Beaumont, A Bennett, NA Keating, DA White, DJ Hosking
Postgraduate medical journal 1998
Osteoporosis
DL Glaser, FS Kaplan
Spine 1997
Osteogenesis imperfecta and other heritable disorders of bone
CR Paterson
Baillière's Clinical Endocrinology and Metabolism 1997
Bone Histomorphometry in Adults With Type IA Osteogenesis Imperfecta:
EF McCarthy, K Earnest, K Rossiter, J Shapiro
Clinical Orthopaedics and Related Research® 1997
Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta
DA Redford-Badwal, ML Stover, M Valli, MB McKinstry, DW Rowe
Journal of Clinical Investigation 1996
Multiexon Deletions in the Type I Collagen COL1A2 Gene in Osteogenesis Imperfecta Type: IB MOLECULES CONTAINING THE SHORTENED α2(I) CHAINS SHOW DIFFERENTIAL INCORPORATION INTO THE BONE AND SKIN EXTRACELLULAR MATRIX
S Mundlos, D Chan, YM Weng, DO Sillence, WG Cole, JF Bateman
The Journal of biological chemistry 1996
Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: Influence of age
NS Fedarko, P D'Avis, CR Frazier, MJ Burrill, V Fergusson, M Tayback, PD Sponseller, JR Shapiro
Journal of Bone and Mineral Research 1995
Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen
MC Willing, SP Deschenes, DA Scott, PH Byers, RL Slayton, SH Pitts, H Arikat, EJ Roberts
The American Journal of Human Genetics 1994
Reduced serum levels of car☐y-terminal propeptide of human type I procollagen in a family with type I-A osteogenesis imperfecta
S Minisola, AL Piccioni, R Rosso, E Romagnoli, MT Pacitti, L Scarnecchia, G Mazzuoli
Metabolism 1994
Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta
ML Stover, D Primorac, SC Liu, MB McKinstry, DW Rowe
Journal of Clinical Investigation 1993
Collagens and their Abnormalities in a Wide Spectrum of Diseases
KI Kivirikko
Annals of Medicine 1993
Type II collagen defect in two sibs with the Goldblatt syndrome, a chondrodysplasia with dentinogenesis imperfecta, and joint laxity
J Bonaventure, R Stanescu, V Stanescu, JC Allain, MP Muriel, D Ginisty, P Maroteaux
American Journal of Medical Genetics 1992

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts